The ability to regulate the consolidation and strengthening of memories for threatening experiences is critical for mental health, and its dysregulation may lead to psychopathologies. Re-exposure to the context in which the threat was experienced can either increase or decrease fear response through distinct processes known, respectively, as reconsolidation or extinction. Using a context retrieval-dependent memory-enhancement model in rats, we report that memory strengthens through activation of direct projections from dorsal hippocampus to prelimbic (PL) cortex and activation of critical PL molecular mechanisms that are not required for extinction. Furthermore, while sustained PL brain-derived neurotrophic factor (BDNF) expression is required for memory consolidation, retrieval engages PL BDNF to regulate excitatory and inhibitory synaptic proteins neuroligin 1 and neuroligin 2, which promote memory strengthening while inhibiting extinction. Thus, context retrieval-mediated fear-memory enhancement results from a concerted action of mechanisms that strengthen memory through reconsolidation while suppressing extinction.
a r t I C l e S Memory consolidation, the process of stabilization and storage of long-term memories 1, 2 , and its modulation are fundamental functions for survival. In contextual fear memories, this process engages a functional crosstalk between the dorsal hippocampus (dHC) and cortical regions [3] [4] [5] [6] . Although hippocampal molecular mechanisms underlying long-term memory consolidation have been relatively well characterized, the related cortical mechanisms remain largely unknown.
Memory consolidation can be modulated through context retrieval, the re-experience of contextual stimuli without reinforcement, to either strengthen or weaken memory retention via reconsolidation or extinction processes, respectively. Reconsolidation, the process of restabilizing a memory after it has been destabilized by retrieval, mediates memory strengthening 7, 8 , whereas extinction entails new learning that results in a decrease of the conditioned fear response 9, 10 . The two processes employ distinct mechanisms and can be doubly dissociated 11, 12 .
Using the contextual fear-based inhibitory avoidance (IA) task in rats, we previously found that brief, nonreinforced context retrievals strengthen the memory through reconsolidation 7 , which requires de novo translation in the basolateral amygdala (BLA) 13, 14 . Recently, Fukushima et al. 8 reported that IA memory enhancement evoked by context retrieval in mice requires amygdala, dHC and medial prefrontal cortex (mPFC) through the simultaneous activation of calcineurin-induced proteasome-dependent protein degradation and the transcription factor cAMP-responsive element binding protein (CREB). However, important questions remain to be addressed: why do retrieval events, in certain conditions, lead to memory enhancement rather than extinction? How do dHC and mPFC generate memory consolidation and enhancement? Are there subregions of the mPFC critically implicated in memory enhancement versus extinction? Is there a functional link between reconsolidation and extinction? And finally, which molecular, cellular and behavioral mechanisms mediate memory enhancement? The answers to these questions will elucidate circuitry and molecular mechanisms underlying fear memory strengthening or weakening, important information for investigating abnormal fear responses and hopefully identifying corrective approaches.
Here we employed a protocol based on three retrievals (3Rs) following IA training in rats 7 , to identify hippocampal-cortical functional circuitry and mechanisms of context retrieval-induced memory strengthening. We show that 3Rs enhance fear memory by engaging direct functional connectivity between the dHC and the PL subregion of mPFC and by engaging two types of biological mechanisms in the PL cortex: one that promotes memory strengthening and another that inhibits extinction.
RESULTS
Activity-regulated cytoskeleton-associated protein Arc in dHC and mPFC is required for memory enhancement Rats were trained in the IA task or remained in the home cage (nontrained, naive group, N). Memory reactivation started 2 d after training and consisted of a total of three brief (10-s) re-exposures to the context (the lit compartment of the IA box), given with an interval between re-exposures of 2 d (3Rs). Rats that were trained but did not undergo memory reactivation (nonreactivated group, NoR) were used as controls. We also included another control group of rats, which was trained and exposed three times to a new, different context (3Cs) instead of the reactivation trials. The 3Rs protocol, given during the first week after training, was previously shown to produce significant memory enhancement through memory reconsolidation 7 . a r t I C l e S First, we confirmed that the 3Rs protocol led to significant memory enhancement (Fig. 1a) . Western blot analyses then showed that 3Rs had significantly increased levels of the activity and/or plasticity marker Arc (also called Arg3.1) 15 in the dHC, BLA, mPFC and anterior cingulate cortex (ACC) 1 h after the last context retrieval, compared to both N and NoR conditions ( Fig. 1b) .
Compared to a control scrambled oligodeoxynucleotide (ODN), a bilateral injection of antisense ODN against Arc 1 h before each retrieval in the dHC completely blunted retrieval-mediated memory enhancement, without affecting either the memory in the absence of retrievals (NoR) or memory retrieval per se ( Fig. 1c and  Supplementary Fig. 1a ). In line with previous studies on protein synthesis inhibition 8, 13 , Arc antisense injection into the BLA significantly disrupted the memory (compared to scrambled ODN-injected 3Rs or NoR groups; Fig. 1c ). This disruption persisted for 1 week, and memory was not rescued by a reminder shock given in a different context (Supplementary Fig. 1b) , a protocol that reinstates extinguished fear memories 7 . This suggests that BLA mechanisms of de novo gene expression, including Arc translation, mediate IA memory reconsolidation. Similarly to what was found with the dHC, Arc antisense injections into the PL or the infralimbic (IL) subregions of mPFC before each retrieval completely blocked retrieval-mediated memory enhancement without affecting the memory in the NoR groups ( Fig. 1c) . Finally, Arc antisense injections in the ACC had no effect on retrieval-mediated memory enhancement, indicating that not all prefrontal cortical regions are similarly engaged ( Fig. 1c) .
We concluded that context retrieval during the first week following IA training induces Arc expression in multiple brain regions, which is critical for processing contextual fear memories. While Arc induction in the dHC, PL and IL mediates memory enhancement, Arc induction in the BLA mediates memory reconsolidation.
Retrieval-mediated Arc induction in dHC controls molecular mechanisms in mPFC underlying memory enhancement
We next identified additional molecular correlates of memory enhancement in the dHC and mPFC. Western blot analyses were employed to quantify the relative activation of two mechanisms critical for long-term plasticity and memory formation: the phosphorylation of the transcription factor CREB at Ser133 (pCREB), and the phosphorylation of the actin severing protein cofilin at Ser3 (p-cofilin) 16, 17 . The 3Rs protocol significantly increased both pCREB and p-cofilin, but not total CREB and cofilin, in both dHC and mPFC compared to N, NoR and 3Cs ( Fig. 2a and Supplementary Fig. 2) . Although the 3Cs protocol did not produce memory enhancement ( Fig. 1a) , it significantly increased Arc in both dHC and mPFC ( Fig. 2a ). Furthermore, a single retrieval (1R) given at 6 d after training produced a significant increase in Arc but only a trend toward an increase in pCREB or p-cofilin in both dHC and mPFC ( Fig. 2a) . These data suggest that the induction of pCREB and p-cofilin, but not of Arc, correlates with memory enhancement.
Given the behavioral and molecular similarities between dHC and mPFC, we next asked whether they functionally interact to promote memory strengthening. Previous studies suggested that hippocampal input to cortical regions is important for memory consolidation and strengthening through sleep and/or slow-wave oscillations during rest periods after training 18 . Hence, we tested whether molecular changes evoked by the 3Rs protocol in the dHC directly control changes occurring in the mPFC. Arc antisense or scrambled control ODN was bilaterally injected into the dHC before each retrieval to block hippocampal Arc induction. Control rats (NoR group) received similar injections at matched time points in the absence of the 3Rs protocol. 38 , P < 0.0001, n = 9, 6, 11, 11; IL F 3,28 = 3.693, P = 0.0234, n = 8, 5, 9, 10; ACC F 2,14 = 6.565, P = 0.0097, n = 6, 5, 6; three independent experiments). *P < 0.05, **P < 0.01, ***P < 0.001. Histological images showing the injection sites are presented in Supplementary Figure 10 . Full-length blots are presented in Supplementary Figure 11 . a r t I C l e S dHC and mPFC protein extracts, obtained 1 h after the last retrieval or at the matched time point for the NoR group, were examined using western blot analyses. Compared to scrambled controls, Arc antisense completely blocked the 3Rs-evoked increase of Arc, pCREB and p-cofilin not only in the dHC ( Fig. 2b) but also-remarkably-in the mPFC (Fig. 2b) . Arc antisense injections into the dHC of NoR rats did not change the levels of any of these proteins in either dHC or mPFC ( Fig. 2b) . Thus, functional crosstalk between the dHC and the mPFC underlies retrieval-mediated memory enhancement.
Direct functional dHC-to-PL cortex projections mediate memory enhancement We next asked whether neuronal activity of direct projections from dHC to specific subregions of the mPFC plays a critical role in memory enhancement. Within the mPFC, the IL cortex is known to mediate fear extinction, while the PL cortex plays a critical role in the expression of conditioned fear 19, 20 . Here we tested whether the neuronal activity of direct projections from dHC to PL or IL cortex is involved in memory strengthening evoked by the 3Rs protocol. To verify the specificity of effects on memory strengthening, we also investigated the role of the same neuronal activation on extinction, which was evoked by confining the animals in the dark compartment of the IA box for 5 min in the absence of footshock following a standard IA test (Ext). Western blot analyses measuring Arc, pCREB and p-cofilin confirmed that the dHC was activated with both 3Rs protocols, as well as with Ext given 6 d after IA training; in fact, all these markers were significantly induced with either 3Rs protocols or extinction, compared to what we found in the N and NoR groups (P = 0.0002 for Arc, P = 0.0003 for pCREB, and P = 0.0011 for p-cofilin; Supplementary  Fig. 3 ). Virus-mediated expression of designer receptors exclusively activated by designer drugs (DREADD) in dHC projection neurons was combined with local infusion of DREADD ligand clozapine-N-oxide (CNO) to silence neurotransmission in the PL cortex 21, 22 . Adeno-associated virus 8 (AAV8)-expressing Gi-coupled DREADD hM4Di (AAV8/hSyn-HA-hM4Di-IRES-mCitrine), which silences neurotransmission in the presence of CNO 23 , was injected bilaterally into the dHC. In addition to hM4Di, this viral vector also expressed a fluorescent protein, mCitrine, independent of hemagglutinin (HA)-hM4Di in the infected neurons using the internal ribosome entry site (IRES). Unlike HA-hM4Di, which is a transmembrane protein labeling neuronal processes including long projections, mCitrine is a soluble protein and labels the somata and proximal processes of the infected cells. Four to six weeks after viral injection, infection of dHC but not of ventral hippocampal neurons was revealed by somatic mCitrine expression. Expression of hM4Di was detected in both the somata and neurites of infected dHC neurons but not in the ventral hippocampus ( Supplementary Fig. 4a ). Consistent with previous reports using a variety of retrograde tracing techniques showing a small population of dHC neurons projecting to the mPFC [24] [25] [26] , in the animals injected with AAV8/hSyn-HA-hM4Di-IRES-mCitrine into the dHC, the PL cortex showed sparse hM4Di expression, indicating direct projections from the dHC to the PL cortex ( Supplementary  Fig. 4b ).
No mCitrine-labeled neurons were detected in the PL cortex, excluding off-target AAV infection. This direct projection from dHC to PL cortex was further verified and confirmed using retrograde tracer cholera toxin B. Injection of cholera toxin B into the PL cortex resulted in labeling of CA2 neurons in the rostral sections of dHC and additional sparse labeling of CA1 neurons in the caudal dHC sections ( Supplementary Fig. 5a,b) . Bilateral injection of CNO into the PL cortex of rats expressing hM4Di in dHC neurons significantly reduced 3Rs-evoked Arc induction in the PL cortex, compared to control groups (vehicle-injected group, or rats expressing GFP in place of hM4Di in dHC neurons and injected with CNO; P < 0.0001). No effect on Arc levels was found in the NoR group or in the IL cortex ( Supplementary Fig. 5c ). Compared to vehicle, CNO injection into the PL cortex completely blocked 3Rs-evoked memory enhancement. This effect persisted and did not change after a reminder shock, indicating that memory blockade was not due to a facilitated extinction but rather to a disruption of memory strengthening ( Fig. 3a) . No effect of CNO injection into the PL cortex was found in the NoR group. Furthermore, injection of CNO into the PL cortex in rats expressing the control virus AAV8/hSyn-GFP in the dHC had no effect on memory retention, excluding nonspecific behavioral effects caused by the virus and/or CNO ( Fig. 3a) .
To determine whether the dHC-to-PL direct projections are selectively involved in retrieval-mediated memory enhancement, we tested whether blocking the same neuronal activity had any effect on extinction. a r t I C l e S Rats bilaterally infected with AAV8/hSyn-HA-hM4Di-IRES-mCitrine in the dHC and injected with CNO in the PL cortex displayed extinction similarly to vehicle-injected controls (Fig. 3b) . These data suggest that direct projections from dHC to PL cortex are recruited in memory strengthening but are not involved in extinction. Furthermore, as we found that dHC also sends direct projections to the IL cortex of mPFC ( Supplementary Fig. 4b ), a region known to mediate extinction, we employed the DREADD system to examine the role of neuronal activity of direct dHC-to-IL cortex projections in extinction. Extinction was completely blocked by a bilateral CNO injection into the IL cortex of rats whose dHC were infected with AAV8/hSyn-HA-hM4Di-IRES-mCitrine, compared to control virus AAV8/hSyn-GFP (Fig. 3b) .
Collectively, these data showed that retrieval-evoked memory enhancement requires the activation of direct functional projections from the dHC to PL cortex. This activation functionally engages Arc and leads to phosphorylation of CREB and cofilin in the PL cortex. In contrast, extinction engages direct functional projections from the dHC to IL cortex.
PL BDNF mediates memory consolidation and extinction inhibition
Next we investigated PL cortical mechanisms underlying retrievalmediated memory enhancement. Given that the induction of pCREB and p-cofilin correlates with memory enhancement and that CREBdependent gene expression, as well as synaptic structural changes accompanying synaptic plasticity and memory consolidation, is regulated by BDNF 27, 28 , we hypothesized that BDNF is an upstream critical mediator of memory enhancement. Western blot analyses showed that the levels of BDNF and of the phosphorylation of its receptor TrkB (pTrkB), but not total TrkB levels, were significantly increased in the mPFC 6 d after IA training compared to the N group ( Fig. 4a and Supplementary Fig. 2) . These upregulations were observed starting 30 min after training and persisted for at least 1 week ( Fig. 4b) .
Similar increases were also observed in the 3Rs group but not in the 1R or 3Cs groups ( Fig. 4a and Supplementary Fig. 2) .
To block the functional role of BDNF in the PL cortex during either memory consolidation or enhancement, a functional anti-BDNF blocking antibody was injected bilaterally into the PL cortex 30 min before each retrieval or at matched time points in the absence of retrievals (NoR). Selective targeting of PL cortex injection is shown in Supplementary Figure 6a .
Compared to IgG controls, the anti-BDNF injections in the absence of retrieval significantly disrupted memory retention when tested 8 d after training. The impairment persisted as shown by another test 5 d later. The memory impairment also remained after a reminder shock, suggesting that memory consolidation requires a long-lasting BDNF-dependent function in the PL cortex ( Fig. 4c) . In contrast, in the rats that underwent 3Rs, PL anti-BDNF injection before each retrieval produced a distinctive outcome compared to injections of IgG: it selectively blunted memory enhancement without decreasing retention below that evoked by training ( Fig. 4c) . This effect persisted, as shown by another test 5 d later. However, a reminder shock fully rescued memory performance ( Fig. 4c) , indicating that the decrease in memory retention by anti-BDNF reflected a facilitated extinction, rather than a disruption of memory. This effect of BDNF was different than that of other PL cortical mechanisms, such as the 3Rs-evoked Arc expression, which selectively targeted memory strengthening but did not affect extinction ( Fig. 1c and Supplementary Fig. 6b ). Thus, these data imply that parallel molecular mechanisms are engaged in the PL cortex following context retrievals; these mechanisms, in concert, promote memory strengthening and extinction inhibition. Supplementary Figure 10 . Full-length blots are presented in Supplementary Figure 12. a r t I C l e S BDNF in PL cortex regulates neuroligin 1/neuroligin 2 ratio to promote memory consolidation or enhancement BDNF signaling can regulate both excitatory and inhibitory synapse formation and function 29 . Given that the balance between excitation and inhibition in the mPFC may critically contribute to fear memory expression and extinction 30, 31 , we first investigated whether a change in the ratio of excitatory/inhibitory synapses accompanies 3Rs-mediated IA memory enhancement. Toward this end, we employed western blot analyses to determine whether BDNF in the PL cortex regulates the expression of neuroligin 1 (NLGN1) and neuroligin 2 (NLGN2), markers of maturation of excitatory and inhibitory synapses, respectively 32 . Like BDNF and pTrkB, both NLGN1 and NLGN2 in the mPFC significantly increased 6 d after IA training compared to naive conditions ( Fig. 5a ), suggesting that both excitatory and inhibitory synapse maturation accompany memory consolidation. Following 1R and 3Rs protocols, but not after 3Cs, NLGN1 remained increased, while NLGN2 returned to its baseline level after context retrieval or exposure to 3Cs (Fig. 5a) . Thus, the 3Rs protocol significantly changed the ratio of NLGN1/NLGN2 (Fig. 5a ) in favor of an overall enhancement of excitatory synapse maturation, thereby suggesting its functional contribution. Consistent with the conclusion that 3Rs enhance excitatory synapse maturation, glutamate receptor 1 (GluA1) increased after 1R and 3Rs, and glutamate receptor 2 (GluA2) increased after 3Rs (Supplementary Fig. 7) . Hence, IA training produced a longlasting increase in the levels of proteins associated with both inhibitory and excitatory synapse formation and maturation in the mPFC; furthermore, context retrieval, but not exposure to a different context, increased the excitatory-to-inhibitory synapse ratio.
Blocking BDNF with anti-BDNF antibody in the absence of retrieval blunted the training-induced increase of both NLGN1 and NLGN2 (Fig. 5b) . However, blocking BDNF at each retrieval trial significantly blocked the NLGN1 induction but did not reverse the NLGN2 decrease, suggesting that the latter is mediated by BDNF-independent mechanisms (Fig. 5b) . In sum, blocking BDNF significantly reversed the increased NLGN1/NLGN2 ratio after 3Rs (Fig. 5b) . We concluded that BDNF signaling in the PL cortex differentially regulates inhibitory and excitatory synapse maturation after training to promote memory consolidation or after context retrieval to promote enhancement.
The role of NLGN1 and NLGN2 in memory consolidation, strengthening and extinction inhibition We next examined the functional requirements for NLGN1 and NLGN2 in the PL cortex during either memory consolidation or 3Rsevoked memory enhancement. The effect of bilateral injection into the PL cortex of the functional competitor extracellular domain of either NLGN1 or NLGN2 30 min before each retrieval, or at the matched time points in the NoR group, was tested 8 d after training. Blocking NLGN1 had no effect on memory retention in the NoR group but completely reversed retrieval-mediated memory enhancement (Fig. 6a) . This blockade persisted as shown by another test 5 d later, and the retention was not rescued by a reminder shock. Hence, functionally blocking NLGN1 produced a behavioral effect similar to that found when Arc expression was blocked ( Fig. 1c and Supplementary Fig. 6b) . In contrast, functional disruption of NLGN2 in the NoR group significantly and persistently disrupted memory retention tested 8 d after training and again 5 d later. The impairment remained following a reminder shock (Fig. 6a) , indicating a persistent role of PL inhibitory synapses in IA memory consolidation. On the other hand, disrupting NLGN2 function at each retrieval trial blunted memory enhancement without further disrupting the memory. The blunting effect persisted over time, but notably, a reminder shock fully rescued memory enhancement ( Fig. 6a ), suggesting that, as with anti-BDNF, disrupting NLGN2 function promoted extinction.
To further understand the differential roles of NLGN1 and NLGN2 in memory enhancement or extinction inhibition, respectively, we investigated the activation of the PL and IL subregions of the mPFC using Arc expression as a readout 15 . A bilateral injection of an NLGN1 inhibitor in the PL cortex 30 min before each retrieval trial significantly reduced Arc expression, whereas injection of NLGN2 inhibitor significantly increased Arc expression ( Fig. 6b) . These data confirmed previous findings that NLGN1 and NLGN2 differentially mediate excitatory and inhibitory synaptic activity 32 , hence promoting or inhibiting neuronal activation, respectively. In agreement with our behavioral results, these data also suggest that while NLGN1 and Arc promote memory strengthening via neuronal activation (Figs. 1c and 6a and Supplementary Fig. 6b ), NLGN2 inhibits neuronal activation a r t I C l e S and targets a different PL cortical mechanism, i.e., as indicated by our behavioral data, extinction inhibition (Fig. 6a) .
To support this conclusion, we tested whether NLGN2 blockade in the PL cortex caused neuronal activation in the subregion known to mediate extinction: the IL cortex. Indeed, blocking NLGN2 in the PL cortex in the 3Rs condition increased Arc levels in both the PL and IL cortices, with the strongest effect in the IL cortex (Fig. 6b) . Moreover, blocking PL NLGN1 in the 3Rs condition also led to IL cortex activation, but to a lesser degree (Fig. 6b) . We concluded that NLGN1 and NLGN2 act in opposite directions in the PL cortex to functionally regulate IL cortex activation, suggesting that they likely target different neuronal populations. Together with the behavioral outcome, these data suggest that PL NLGN2 inhibits PL cortical neurons whose function is to activate the IL cortex. Thus, this PL NLGN2-mediated inhibition ultimately suppresses extinction.
To further support this conclusion, we measured the levels of neuronal activation in an extinction paradigm. We predicted that with extinction there should be a decrease in NLGN2 in the PL cortex and more activation of the IL cortex. We therefore compared the activation of the PL and the IL cortices in the 3Rs protocol, which, as shown, evokes memory enhancement (3Rs-Enh), with a similar protocol that has previously shown to evoke IA extinction given 4 weeks after training (3Rs-Ext) 7 . Neuronal activation was measured by the expression of Arc. a r t I C l e S The number of Arc-positive cells significantly increased in the PL and the IL cortices after both enhancement and extinction protocols; however, the increase was significantly higher in the IL cortex after 3Rs-Ext compared to 3Rs-Enh, consistent with previous findings that IL cortex activation is critical for memory extinction 19, 20 (Fig. 7a) .
Furthermore, western blot analysis of 3Rs-Enh and 3Rs-Ext revealed opposing trends in NLGN1 and NLGN2 expression regulation: while in the first week after training, as well as with 3Rs-Enh, NLGN1 was significantly increased in the mPFC (Fig. 5a) ; 32 d later, NLGN1 significantly decreased below the level in control N rats (Fig. 7b) . NLGN2, which was increased (and required for memory formation) in the first week following training, decreased below control N levels 32 d later. Compared to NoR, 3Rs-Ext did not significantly change the levels of NLGN1 and NLGN2 (Fig. 7b) .
BDNF and NLGN2 in the PL cortex inhibit extinction
To further dissect the PL molecular mechanisms involved in 3Rs-evoked memory enhancement compared to extinction, we additionally investigated the Ext protocol. N and NoR groups served as controls. Western blot analyses revealed that changes in Arc, pCREB, p-cofilin, BDNF, pTrkB, NLGN1 and NLGN2 in the PL cortex following 3Rs were similar to those previously reported with the whole mPFC. In contrast, extinction resulted in an increase in Arc in the PL cortex but no changes in pCREB, p-cofilin, BDNF, pTrkB and NLGN1 (Supplementary Fig. 8 ). This suggested that extinction correlates with a very different pattern of PL cortical molecular changes.
Bilateral injections into the PL cortex of Arc antisense, anti-BDNF or inhibitors of NLGN1 or NLGN2 before extinction learning (all of which, as shown above, blunted retrieval-mediated memory enhancement; Figs. 1c, 4c and 6a ) had no effect on memory retrieval or extinction ( Fig. 8 ), suggesting that differential molecular mechanisms are involved in retrieval-mediated memory enhancement versus extinction. Finally, to test whether blocking PL BDNF or NLGN2 enhances extinction, as suggested by our experiments shown in Figures 4c and 6a , we employed a weak extinction protocol. In this protocol, during testing the rats were confined to the dark compartment of the IA box for 1 min upon entering. As shown in Figure 8c ,d, blocking PL BDNF or NLGN2 significantly enhanced extinction, supporting the conclusion that these mechanisms can indeed inhibit extinction. Collectively, these data indicate that Arc, BDNF, NLGN1 and NLGN2 in the PL cortex are specifically engaged in retrieval-mediated memory enhancement and that BDNF and NLGN2 in the PL cortex contribute to memory enhancement by inhibiting extinction.
DISCUSSION
The consolidation and retrieval-dependent modulation of long-term fear memories greatly influence the regulation of emotions and the development of psychopathologies. Here we provide an innovative understanding of the circuitry and molecular mechanisms underlying consolidation, retrieval-dependent threat memory enhancement and extinction.
First, we showed that IA consolidation required several days of persistent BDNF upregulation in the PL cortex. These data significantly extend the findings that BDNF and TrkB play a critical role in the PL cortex for both appetitive and fear learning in mice 33, 34 . We also showed that PL BDNF controlled the upregulation of both NLGN1 and NLGN2 in the PL cortex. To our knowledge, our data are the first to report changes of endogenous NLGN1 and NLGN2 following training in the PL cortex and their dependence on PL BDNF. Furthermore, and in line with a recent report employing a conditional NLGN2 knockout in mPFC 35 , our results reveal a critical role for NLGN2 in the PL cortex during the first week of IA memory consolidation, suggesting that the sustained inhibitory synapse function is an essential a r t I C l e S mechanism of memory consolidation. These results are important in light of the imbalance of the excitation-to-inhibition ratio documented in cortical areas in models of neuropsychiatry disorders 36 . Second, we showed that context retrieval following a recently formed aversive memory engages BLA for memory reconsolidation and activates a direct monosynaptic input from the dHC to the PL cortex. Fukushima et al. 8 recently reported that the dHC and mPFC mediate IA memory enhancement in mice through CREB-mediated gene expression and calcineurin-induced proteasome-dependent protein degradation. Our data significantly extend this information in several ways by showing that (i) direct functional projections from the dHC to PL cortex are necessary for memory strengthening, which occurs via Arc-dependent mechanisms in both regions. To our knowledge, this is the first evidence showing the existence of functional dHC-to-PL cortex direct projections in context retrieval-mediated memory processing. (ii) The dHC activation controls PL cortical molecular mechanisms, including the induction of pCREB, p-cofilin, BDNF, pTrkB and NLGN1, to specifically promote context retrievalinduced memory enhancement. These changes are not involved in context retrieval-induced extinction. (iii) NLGN1 mediates memory strengthening. In parallel, BDNF and NLGN2 modulate memory strengthening by suppressing extinction. In agreement, we also found that blocking BDNF or NLGN2 in the PL cortex not only did not block extinction but actually facilitated it. These data indicate, for the first time to our knowledge, that reconsolidation and extinction are co-regulated and are functionally cooperative processes.
Our data also showed that context retrieval shifts the role of PL BDNF-dependent mechanisms in processing hippocampal-dependent fear memory. Its functional role is required for several days after training to promote memory consolidation; however, with context retrieval, BDNF becomes engaged in inhibiting extinction. We speculate that this shift occurs as a result of the activation of different memory traces that takes place with training versus context retrieval. BDNF, being a common, fundamental plasticity mechanism, likely affects the active trace, thereby promoting distinct molecular and behavioral outcomes in the two behavioral conditions (training versus retrieval). Retrievals, and hence memory enhancement, also resulted in the return to baseline of NLGN2 but not of NLGN1, which produced a net increase in the excitatory over inhibitory synapse ratio. This decrease in inhibitory synapses with retrievals was not BDNF-dependent and can be explained by invoking a regulation of distinct populations of inhibitory synapses.
Several studies have reported that BDNF is a critical mechanism of memory extinction, which is known to mainly involve the IL cortex 37 . How can BDNF be involved in memory enhancement as well as extinction, despite these two processes being mediated by different mechanisms and circuits? We suggest that retrieval protocols and the age of the memory dictate which distinct neural circuit is activated within the dHC, BLA and mPFC neuronal subpopulations to evoke either memory extinction or memory strengthening through reconsolidation. We speculate that such differential regulations may involve modulation of excitatory and inhibitory connections between the PL and the IL cortices, a hypothesis in agreement with the model proposed by Miller and Cohen 38 and by Baldi and Bucherelli 39 . Our speculation is also supported by our findings that memory extinction, compared to enhancement, resulted in greater activation of IL than PL cortex. Extinction also correlated with decreases in NLGN1 and NLGN2 in the mPFC, thus not changing its excitatory/ inhibitory synapse ratio.
Based on our functional results targeting BDNF, NLGN1 and NLGN2 in the PL cortex, we propose, in agreement with Marquis et al. 40 and Ragozzino 41 , that the PL cortex plays an important role in detecting and processing mismatches, thus contributing to behavioral flexibility, i.e., the first encoding of the context associated with a footshock at training is revised at retrieval by context exposure in the absence of footshock. We suggest that this mismatch is accompanied by a significant shift in the molecular regulation of plasticity (through BDNF) that targets the active trace. We also suggest that, in addition to the mismatch detection, other mechanisms, such as the levels of arousal and trace-storage network distribution, contribute to determine when or if the memory is strengthened or extinguished.
In conclusion, the PL cortex and the input it receives from the dHC are important parts of the circuitry that mediates and modulates the strength of hippocampal-dependent fear memory. These mechanisms may represent important targets for threat-induced psychopathologies.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
ONLINE METHODS

Animals.
Adult male Long-Evans rats weighing 200-250 g (age 2-4 months) were used for the experiments. Rats were doubly or individually housed after surgery in the New York University animal facility and maintained on a 12-h light/dark cycle with ad libitum access to food and water. Experiments were performed during the light cycle. All rats were handled for 3 min per d for 5 d before any procedure. All protocols complied with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the New York University Animal Welfare Committee. cannulae implants. Rats were anesthetized with ketamine (75 mg/kg) and xylazine (10 mg/kg). Stainless steel cannulae (22 gauge for dHC, 26 gauge for other brain regions) were implanted stereotactically and bilaterally to target dHC (4.0 mm posterior to bregma, 2.6 mm lateral from midline and 2.0 mm ventral), BLA (2.8 mm posterior to bregma, 5.3 mm lateral from midline, 6.25 mm ventral), PL (14° angle toward midline, 2.8 mm anterior to bregma, 1.45 mm lateral from midline, 2.2 mm ventral), IL (30° angle toward midline, 2.8 mm anterior to bregma, 3.1 mm lateral from midline, 3.3 mm ventral) and ACC (26 gauge, 2.6 mm anterior to bregma, 0.6 mm lateral from midline, 1.3 mm ventral). Rats were given Buprenex (0.1 mg/kg, twice per d for 3 d before and after surgery) or meloxicam (3 mg/kg, once before surgery) for postoperational analgesic treatment and allowed to recover for at least 8 d before training.
Inhibitory avoidance (IA). The IA chamber (Med Associates, St. Albans, VT) consisted of a rectangular Perspex box, divided into a safe (lit) compartment and a shock (dark) compartment. Foot shocks were delivered to the grid floor of the shock compartment via a constant-current scrambler circuit. The two compartments were separated by a sliding door. The chamber was located in a sound-attenuated room illuminated by dim red light. During the training session, each rat was placed in the safe compartment with its head facing away from the door. After 10 s the door was automatically opened, allowing the rat access to the shock compartment, and a 2-s 0.6-mA foot shock was administered. Latency to enter the shock compartment was taken as a measure of acquisition. Ten seconds after delivery of the foot shock, the rat was returned to its home cage. Memory retention was tested at the indicated time points as described in each experiment and performed by placing the rat back into the safe compartment and measuring the latency to enter the shock compartment without administering foot shock. Testing was terminated at 900 s and performed blind to treatments. Memory reactivation consisted of 10-s exposures to the safe compartment. In control experiments, 10-s exposures to a different context (context B) were used. This context (control context used for the 3Cs exposures) consisted of a square chamber (Med Associates, St. Albans, VT) with three transparent walls, an opaque Plexiglas wall and a floor grid with narrow spacing, located in a separate, well-lit room. To test whether memory impairment was due to extinction, animals underwent a 2-s 0.6-mA reminder foot shock in the control context. Naive rats were handled but otherwise remained in the home cage. For memory extinction, rats were tested for memory retention in the IA box, followed by confining the animals in the dark compartment of the IA box for 5 min or 1 min (weak extinction) in the absence of foot shock, as specified.
oligodeoxynucleotides and drug injections. Arc antisense (Arc AS; 5′-GTC CAGCTCCATCTGCTCGC-3′) or relative scrambled ODNs (Arc SC; 5′-CGTG CACCTCTCGCAGCTTC-3′) were dissolved in PBS pH 7.4. The control Arc scrambled ODN contained the same base composition but in a randomized order and showed no homology to any mammalian sequence in the GenBank database. The ODNs were phosphorothioated on the three terminal bases at each end to protect again nuclease degradation. The ODNs were reverse-phase cartridgepurified and purchased from Gene Link (Hawthorne, NY). Rats were injected with 2 nmol of ODNs per side in the dHC (in 1 µL), PL (in 0.3 µL), IL (in 0.2 µL), BLA (in 0.5 µL) or ACC (0.5 µL) 1 h before each 10-s context reactivation trial or at the matched time points in the NoR group. The sheep functionally blocking antibody to BDNF (Millipore, Billerica, MA) or control sheep IgG (Sigma-Aldrich, St. Louis, MO) was dissolved in PBS pH 7.4 and injected at 0.3 µg in 0.3 µL per injection per side into PL. Recombinant extracellular domains of NLGN1 or NLGN2 (R&D systems, Minneapolis, MN) were dissolved in PBS pH 7.4 and injected at 0.12 µg in 0.3 µL per injection per side into PL. These inhibitors were injected 30 min before each 10-s context reactivation trial or at the matched time points for the NoR group. The infusion needles (28 gauge for dHC; 33 gauge for other brain regions) extended 1.5 mm beyond the cannula. Injections were carried out bilaterally with an infusion pump at a rate of 0.333 µL/min with 10-µL Hamilton syringes (for dHC, BLA and ACC) or 0.2 µL/min with 1-µL Hamilton syringes (for PL and IL). The injection needle was left in place for 2 min following the injection to allow for complete flow of the solution. For all behavioral and injection procedures, rats were randomly assigned to different groups. At the end of the behavioral experiments, the brains were collected, sectioned and examined under a light microscope to verify the cannula placement. Rats with incorrect needle placement were discarded from the study. In experiments that involve multiple memory retention tests, rats that lost head-caps during the course of testing were euthanized by CO 2 immediately and therefore not included in the later tests. dissection and western blot analysis. Rats were killed by decapitation. Their brains were quickly dissected and sliced by a brain matrix. The brain regions of interest were dissected quickly with a scalpel in ice-cold dissection buffer. mPFC was collected from brain slices from bregma +3.7 to +2.5 mm, ACC was collected from bregma + 2.5 to −1.6 mm, BLA was collected from bregma −1.6 to −3.6 mm and dHC was collected from bregma −1.6mm to −5.4 mm. The collected tissues were snap-frozen on dry ice. In some experiments, PL and dHC protein extracts were generated from brains frozen in isopentane immediately following decapitation and isolated as punches in a cryostat using a neuro punch (19 gauge, Fine Science Tools, Foster City, CA). The whole tissues collected for each brain region were homogenized in radioimmunoprecipitation assay (RIPA) buffer (150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 5 mM EDTA, 10% glycerol, 50 mM Tris, pH 8.0) supplemented with 0.5 mM PMSF, 2 mM DTT, 1 mM EGTA, 1 µM microcystin LR, 10 mM NaF, 1 mM NaOV, benzamidine, protease inhibitor cocktail and phosphatase inhibitor cocktail II and III (used as recommended by the manufacturer; Sigma, St. Louis, MO). Protein concentration was determined by the Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA). Twenty micrograms (20 µg) of total protein extract per lane were resolved using denaturing SDS-PAGE gels and transferred to Immobilon-FL membranes (Millipore, Billerica, MA) by electroblotting. We used the following primary antibodies: rabbit anti-Arc (1:10,000, Synaptic System, cat# 156 003, Gottingen, Germany), rabbit anti-pCREB (1:1,000, Cell Signaling, cat# 9198, Danvers, MA), rabbit anti-p-cofilin (1:3,000, Abcam, cat# ab12866, Cambridge, MA), rabbit anti-BDNF (1:200, Santa Cruz Biotechnology, cat# sc-546, Santa Cruz, CA), rabbit anti-pTrkB (1:10,000, Abcam, cat# 21491, Cambridge, MA), mouse anti-NLGN1 (1:1,000, UC Davis/NIH NeuroMab Facility, cat# 75-160, Davis, CA; or Synaptic System, cat# 129 111, Gottingen, Germany), rabbit anti-NLGN2 (1:2,000, Synaptic System, cat# 129 203, Gottingen, Germany), rabbit anti-GluA1 (1:2,000, Millipore, cat# AB1504, Billerica, MA), mouse anti-GluA2 (1:1,000, UC Davis/NIH NeuroMab Facility, cat# 75-002, Davis, CA), mouse anti-CREB (1:1,000, Cell Signaling, cat# 9104, Danvers, MA), mouse anti-cofilin (1:2,500, Abcam, cat# ab54532, Cambridge, MA) and rabbit anti-TrkB (1:1,000, Cell Signaling, cat# 4603, Danvers, MA). Mouse anti-actin antibody (1:20,000, Santa Cruz Biotechnology, cat# sc-47778, Santa Cruz, CA) was used for loading normalization. Mouse anti-GAPDH (1:2,000, Millipore, cat# MAB374, Billerica, MA) confirmed that actin did not change across experimental groups ( Supplementary  Fig. 9 ). We also used secondary antibodies anti-rabbit IRDye800CW and antimouse IRDye680 (1:20,000, Li-Cor, Lincoln, NE). Membranes were scanned on the Li-Cor Odyssey imager under nonsaturating conditions. Data were quantified using pixel intensities with the Odyssey software according to the protocols of the manufacturer (Li-Cor, Lincoln, NE).
Viral and clozapine-n-oxide (cno) injections.
Rats were anesthetized with ketamine (75 mg/kg) and xylazine (10 mg/kg). The skull was exposed and holes were drilled in the skull bilaterally above the dHC. A Hamilton syringe with a 28-gauge needle mounted onto a nanopump (KD Scientific, Holliston, MA) was stereotactically inserted into the dHC (4.2 mm posterior to bregma, 2.6 mm lateral from midline and 3.2 mm ventral). AAV8/hSyn-HA-hM4Di-IRES-mCitrine or AAV8/hSyn-GFP (2.1 × 10 12 genomic copies/mL, 2 µL per side; UNC Vector Core, Chapter Hill, NC) was microinjected at a rate of 0.4 µL/min. The needle was left in place an additional 5 min following microinjection to ensure complete diffusion of the AAV and then slowly retracted. The scalp was sutured. Three weeks after AAV injection, the rats received stereotactic cannula implants
